INS and diabetes mellitus: We studied 21 341 participants after excluding 886 participants who withdrew, 236 277 participants who did not report having diabetes, 2667 participants who died before 2013, 1300 participants who only dispensed acarbose and/or insulin and 4886 participants who did not have GLM records since 1 January 2013 (Figure S2).